Education
- B.A. – Biology/Chemistry, Augustana College, Sioux Falls, SD Sept. 1980-May 1984
- M.D. – University of South Dakota School of Medicine and Health Sciences, Sioux Falls, SD May 1984-May 1988
- Ob/Gyn Internship – St. Joseph's Hospital, Chicago, IL, July 1988-June 1989
- Residency Ob/Gyn – University of Chicago Hospital, Chicago, IL, July 1989-June 1992
- Fellowship Gyn/Onc – University of Alabama at Birmingham, Birmingham, AL July 1992-June 1995
- Pending MPH – Johns Hopkins Bloomberg School of Public Health, Baltimore, MD,
Certifications
- National Board of Medical Examiners - diplomate 7/1/99
Part I - passed 6/86
Part II -passed 9/87
Part III- passed 6/89
- Diplomate American Board of Obstetrics and Gynecology #JFP0363342 (11/96)
- Diplomate Division of Gynecologic Oncology (March, 1999)
Experience
- Scientist, Sanford Research/USD, 2003-current
- Gynecological Oncologist, Sioux Valley Clinic Ob/Gyn Ltd. 2000-current
- Professor, Dept. of Ob/Gyn, Sanford School of Medicine 2006-current
- Associate Professor, Sanford School of Medicine 2000-2006
- Chairman Cancer Committee, Sioux Valley Hospital- May 2002-current
- Cancer Advisory Committee, Sioux Valley Hospital- January 2002-current
- American Cancer Society Advisory Board - June 2002-current
- All Women Count Medical Director - January 2002-current
- Commission on Cancer State Chair for South Dakota - July 2002-current
- Cancer Liaison Physician, Sioux Valley Hospital - July 2002-current
- Fourth year Clerkship Director of Ob/Gyn, Sanford School of Medicine - July 2002-current
- Reviewer for Gynecologic Oncology 2002-current
- Reviewer for the International Journal of Gynecologic Cancer 2002-current
- Assistant Professor, Department Ob/Gyn University of Colorado Health Sciences Center August 1999-March 2000
- Assistant Professor, Department Ob/Gyn, Director of Gynecologic Oncology LSUMC Shreveport, July 1995-July 1999
Professional Societies
- American College of Obstetricians and Gynecologists (fellow) Sept 1997-current
- International College of Surgeons (fellow) 1995
- Society of Gynecologic Oncology (fellow) 1996-current
- American College of Surgeons (fellow) October 1998-current
- American Society of Clinical Oncologists 1996-current
- Association of Professors of Gynecology and Obstetrics 1996-current
- Association of Women Surgeons 1998
- Medicine for Humanity 1999-current
- SD Women’s Cancer Network 1999-current
- International Healthcare Development Foundation 2003-current
Research Focus
- Gynecological Oncology Group
- North Central Cancer Treatment Group
- Southwest Oncology Group
- American Cancer Society grant - HPV analysis on the Rosebud Indian Reservation - $25,000 August 2001-July 2002
- Spirit of Eagles grant, sub-recipient of Mayo - HPV and cervical immunology assessment in women on Rosebud and Pine Ridge Indian Reservations. - $50,000 April 2003-March 2004 (NIH)
- Eggers grant- Interaction of HPV and Hormones. $10,000, July 2003-June 2004
- Ovarian cancer, Cervical Cancer
Publications
- Nauman RW, Bell MC, Alvarez RD, Edwards RP, Partridge EE, Helm CW, Shingleton HM. McGee JA, Higgins RV, Hall JB. LLETZ is an acceptable alternative to diagnostic cold-knife conization. Gynecol Oncol, 55(2), pp 224-228, Nov. 1994.
Bell MC, Edwards RP, Crowley-Norwick PA, Partridge EE: CD8+ lymphocytes are recruited to the dysplastic cervix. J Clin Immun, Vol. 15, No. 3, pp 130-136, May 1995.
Bell MC, Alvarez R, Connor M. Squamous cell carcinoma arising in an immature teratoma of the cervix in an HIV positive patient – a case report. Gynecol Oncol, Vol. 60, pp 475-479, 1996.
Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside T. Alterations in expression and function of signal transducing proteins in tumor-associated T and Natural Killer cells in patients with ovarian carcinoma. Clinical Cancer Research ,Vol. 2, pp 161-173.
Bell MC and Partridge EE. Early breast carcinoma: overview of risk factors, screening, and treatment. Contemporary OB/GYN, pp 31-51, Dec. 1995.
Shingleton HW, Bell MC, Fremgen A, Jones WB, Russell AH, Oewieja K, Winchester D, Clive R, Chmiel J. Is there really a difference in survival of women with early stage squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer, Vol. 76, No. 10, pp 1948-1955, Nov. 15, 1995.
Crowley-Nowick PA, Bell, MC, Edwards R, McCallister D, Gore H, Kanbour-Shakir A, Mestecky J, Partridge E. Normal Uterine Cervix: Characterization of Isolated Lymphocyte Phenotypes and Immunoglobulin Secretion. American Journal of Reproductive Immunology, (34), pp 241-247, Oct.1995.
Rabinowich H, Suminami Y, Reichert T, Crowley-Nowick PA, Bell MC, Edwards R, Whiteside T. Expression of cytokine genes or proteins and signaling molecules in lymphocytes associated with human ovarian cancer. Int. J. Cancer, (68), pp 276-284, 1996.
Lai P, Rabinowich H, Crowley-Nowick PA, Bell MC, Mantovani G, Whiteside T. Alterations in Expression and Function of Signal-transducing Proteins in Tumor-associated T and Natural Killer Cells in Patients with Ovarian Carcinoma. Clinical Cancer Research, Vol. 2, pp 161-172, Jan. 1996.
VonZons P, Crowley-Nowick PA, Friberg D, Bell MC, Koldovsky U, Whiteside T. Comparison of europium and chromium release assays: Cytotoxicity in healthy individuals and patients with cervical carcinoma. Clinical and Diagnostic Laboratory Immunology, pp 202-207, Mar. 1997.
Corwley-Nowick PA, Bell MC, Brockwell R, Edwards RP, Chen S, Partridge EE, Mestecky J. Rectal Immunization for Induction of Specific Antibody in the Genital tract of Women: J Clin Immunol, Vol. 17, No. 5, pp 370-379, 1997.
Ampil FL, Bell MC, Martin D. Reappearance of cancer of the cervix 19 years after radiotherapy: Acta Obstet Gynecol Scan, 76, pp 605-606, 1997.
Ampil FL, Bell MC, Meyers P. CT-Detected Hydrometra Before Irradiation for Cancer of the Cervix: Eur J Gynecol Oncol, Vol. 18, pp 368-370, 1997.
Lai P, Ravinowich H, Crowley-Nowick PA, Bell MC , Mantovani G, Whiteside TL. Alterations of expression and function of signal transducing proteins in tumor-associated T and natural killer cells in ovarian carcinoma. Biochem Soc Trans, 25(2):218S, 1997.
Ampil FL and Bell MC. Brachytherapy in the presence of pyuria after irradiation for cervical cancer: Eur J of Gyn. Onc., Vol 19, pp 350-351, Sept. 1998.
Rabinowich H, Reichert TE, Kashi Y, Gastman BR, Bell MC, Whiteside TL. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. J. Clin. Invest., Vol. 101, No. 11, pp 2579-2588, June 1998.
Ampil FL and Bell MC. Aggressive radiotherapy for stage IIIB cancer of the cervix: Helpful or Harmful? Acta Obstet Gynecol Scand, 77, p 359, 1998.
Ampil FL, Apple S, Bell MC. Spinal epidural compression complicating cancer of the cervix: review of seven cases. Eur J Gynecol Oncol, 19(2), pp 105-107, 1998.
Maihles JB, Carabatsos MJ, Young D, London SN, Bell MC, Albertini DF. Taxol-induced meiotic maturation delay, spindle defects, and aneuploidy in mouse oocytes and zygotes. Mutation Research, Vol. 423, pp 79-90, 1999.
Ampil FL and Bell MC. Pelvis Malignancy in female nonagenarians. Eur J Gynecol Oncol, 20(2), pp 102-104, 1999.
Bell MC, Schmidt-Grimminger D, Turbat-Herrera E, Tucker A, Harkins L, Prentice N, Crowley-Nowick PA. HIV+ Patients have increased lymphocyte infiltrates in CIN lesions. Gynecol Oncol, Vol. 76, pp 315-519, 2000.
Bell MC, Crowley-Nowick PA, Bradlow HL, Sepkovic DW, Schmidt-Grimminger DC, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM. Placebo-controlled trial of Indole-3-carbinol in the treatment of cervical dysplasia. Gynecol Oncol, 78, pp 123-129, 2000.
Bell MC, Davidson SA, Mathis JM, Ampil FL. Topotecan Concomitant with Primary Radiation in patients with cervical carcinoma, A Phase I Trial. Gynecol Oncol, 80(2), pp 128-131, 2001.
Follen M, Meyskens FL Jr, Alvarez RD, Walker JL, Bell MC, Storthz KA, Sastry J, Roy K, Richards-Kortum R, Cornelison TL. Cervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers. Cancer, Nov .1, p 98 (9 Suppl), pp 20044-20051, 2003.
Timble EL, Bell MC, Wolf J, Alvarez R. Grantsmanship and Career Development for Gynecologic Cancer Investigators. Cancer, Nov. 1, p 98 (9 Suppl), pp 2075-2081, 2003.
Bell MC amd Alvarez RD. Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplsia. Int J Gynecol Cancer, 15(1), pp 4-12, 2005.
- Book Chapters:
Carroll, JL, Mathis JM, Bell MC, Santoso JT. “p53 adenovirous as gene therapy for ovarian cancer”. Methods and Molecular Medicine: Ovarian Cancer, Humana Press, Tanaka, NJ (1998) In press.
|
